Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 812

1.

Recurrence and Severe Worsening of Hepatotoxicity After Reintroduction of Atorvastatin in Combination With Ezetimibe.

Bergland Ellingsen S, Nordmo E, Tore Lappegård K.

Clin Med Insights Case Rep. 2017 Sep 25;10:1179547617731375. doi: 10.1177/1179547617731375. eCollection 2017.

2.

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.

Bohula EA, Wiviott SD, Giugliano RP, Blazing MA, Park JG, Murphy SA, White JA, Mach F, Van de Werf FJ, Dalby AJ, White HD, Tershakovec AM, Cannon CP, Braunwald E.

Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095. doi: 10.1161/CIRCULATIONAHA.117.029095. [Epub ahead of print]

PMID:
28972004
3.

Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients.

Guimarães ES, Cerda A, Dorea EL, Bernik MMS, Gusukuma MC, Pinto GA, Fajardo CM, Hirata MH, Hirata RDC.

Cardiovasc Ther. 2017 Sep 21. doi: 10.1111/1755-5922.12307. [Epub ahead of print]

PMID:
28940978
4.

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes.

Fanaroff AC, Roe MT, Clare RM, Lokhnygina Y, Navar AM, Giugliano RP, Wiviott SD, Tershakovec AM, Braunwald E, Blazing MA.

J Am Heart Assoc. 2017 Sep 18;6(9). pii: e005840. doi: 10.1161/JAHA.117.005840.

5.

Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia.

Bove M, Fogacci F, Cicero AFG.

Expert Opin Drug Metab Toxicol. 2017 Oct;13(10):1099-1104. doi: 10.1080/17425255.2017.1381085. Epub 2017 Sep 26. Review.

PMID:
28922021
6.

Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients.

Freitas Gouveia M, Trüeb RM.

Skin Appendage Disord. 2017 Aug;3(3):156-160. doi: 10.1159/000468991. Epub 2017 Apr 22.

PMID:
28879192
7.

Chemometric-Assisted Spectrophotometric Method for the Simultaneous Quantitative Determination of Ezetimibe and Simvastatin in Their Combined Dosage Forms.

Heringer de Souza F, Todeschini V, Sangoi MDS.

J AOAC Int. 2017 Sep 6. doi: 10.5740/jaoacint.17-0124. [Epub ahead of print]

PMID:
28877782
8.

Lower Transaortic Flow Rate Is Associated With Increased Mortality in Aortic Valve Stenosis.

Saeed S, Senior R, Chahal NS, Lønnebakken MT, Chambers JB, Bahlmann E, Gerdts E.

JACC Cardiovasc Imaging. 2017 Aug;10(8):912-920. doi: 10.1016/j.jcmg.2017.05.008.

PMID:
28797414
9.

Cholesterol lowering treatment restores blood global DNA methylation in chronic kidney disease (CKD) patients.

Zinellu A, Sotgia S, Sotgiu E, Assaretti S, Baralla A, Mangoni AA, Satta AE, Carru C.

Nutr Metab Cardiovasc Dis. 2017 Sep;27(9):822-829. doi: 10.1016/j.numecd.2017.06.011. Epub 2017 Jun 28.

PMID:
28755807
10.

A Versatile Liquid Chromatographic Method for the Simultaneous Determination of Metformin, Sitagliptin, Simvastatin, and Ezetimibe in Different Dosage Forms.

El-Zaher AA, Elkady EF, Elwy HM, Saleh MAEM.

J AOAC Int. 2017 Jul 27. doi: 10.5740/jaoacint.17-0050. [Epub ahead of print]

PMID:
28748781
11.

Cost-effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients with a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial.

Almalki ZS, Guo JJ, Alahmari A, Alotaibi N, Thaibah H.

Heart Lung Circ. 2017 Jun 15. pii: S1443-9506(17)31261-1. doi: 10.1016/j.hlc.2017.05.139. [Epub ahead of print]

PMID:
28716519
12.

Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients.

Ghanim H, Green K, Abuaysheh S, Patel R, Batra M, Chaudhuri A, Makdissi A, Kuhadiya ND, Dandona P.

Atherosclerosis. 2017 Aug;263:278-286. doi: 10.1016/j.atherosclerosis.2017.06.010. Epub 2017 Jun 7.

PMID:
28711708
13.

Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis.

Thomassen HK, Cioffi G, Gerdts E, Einarsen E, Midtbø HB, Mancusi C, Cramariuc D.

Heart. 2017 Oct;103(20):1619-1624. doi: 10.1136/heartjnl-2016-311040. Epub 2017 Jul 11.

14.

Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial.

Bays HE, Patel MD, Mavros P, Ramey DR, Tomassini JE, Tershakovec AM, Baxter CA.

J Clin Lipidol. 2017 Jul - Aug;11(4):929-937. doi: 10.1016/j.jacl.2017.04.121. Epub 2017 May 8.

PMID:
28647412
15.

Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.

Guglielmi V, Bellia A, Pecchioli S, Della-Morte D, Parretti D, Cricelli I, Medea G, Sbraccia P, Lauro D, Cricelli C, Lapi F.

Atherosclerosis. 2017 Aug;263:36-41. doi: 10.1016/j.atherosclerosis.2017.05.018. Epub 2017 May 20.

PMID:
28599257
16.

Introduction of therapeutic reference pricing in Slovenia and its economic consequences.

Marđetko N, Kos M.

Eur J Health Econ. 2017 May 27. doi: 10.1007/s10198-017-0903-9. [Epub ahead of print]

PMID:
28551727
17.

The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients.

Lin H, Zhang YM.

Int J Cardiol. 2017 Sep 1;242:1-3. doi: 10.1016/j.ijcard.2016.10.083. Epub 2016 Nov 3.

PMID:
28550977
18.

Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.

Stanifer JW, Charytan DM, White J, Lokhnygina Y, Cannon CP, Roe MT, Blazing MA.

J Am Soc Nephrol. 2017 Oct;28(10):3034-3043. doi: 10.1681/ASN.2016090957. Epub 2017 May 15.

PMID:
28507057
19.

Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

Pokharel Y, Chinnakondepalli K, Vilain K, Wang K, Mark DB, Davies G, Blazing MA, Giugliano RP, Braunwald E, Cannon CP, Cohen DJ, Magnuson EA.

Circ Cardiovasc Qual Outcomes. 2017 May;10(5). pii: e003201. doi: 10.1161/CIRCOUTCOMES.116.003201.

PMID:
28506979
20.

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.

Reith C, Staplin N, Herrington WG, Stevens W, Emberson J, Haynes R, Mafham M, Armitage J, Cass A, Craig JC, Jiang L, Pedersen T, Baigent C, Landray MJ; SHARP Collaborative Group.

BMC Nephrol. 2017 May 1;18(1):147. doi: 10.1186/s12882-017-0545-2.

Supplemental Content

Loading ...
Support Center